GlassScriptPhysician profile
Amanda Jankowski
NPI 1114557287
$1,420.45
in general payments reported to CMS, 2019-2025
18 companies · $67.05 in 2025
The $67.05 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.16 · 2022: $61.97 · 2023: $408 · 2024: $859 · 2025: $67.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $413.64 | 2023-2024 | |
| Pfizer INC. | $310.81 | 2023-2025 | |
| Novo Nordisk INC | $216.23 | 2021-2024 | Rybelsus, Ozempic |
| Biohaven Pharmaceutical Holding Company LTD. | $61.97 | 2022 | |
| Inspire Medical Systems, INC. | $60.97 | 2024-2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.66 | 2023 | Xifaxan |
| Lilly USA, LLC | $42.46 | 2024 | Mounjaro, Zepbound, Jardiance |
| Hologic Sales and Service, LLC | $38.07 | 2023 | Aptima |
| Exact Sciences Corporation | $35.49 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $29.89 | 2024 | Airsupra |
| Viiv Healthcare Company | $28.76 | 2024 | Apretude |
| Gilead Sciences, INC. | $22.56 | 2025 | |
| Esperion Therapeutics, INC. | $20.75 | 2024 | Nexletol |
| Glaxosmithkline, LLC. | $20.69 | 2024 | Shingrix, Arexvy |
| E.R. Squibb & Sons, L.L.C. | $18.87 | 2023 | Eliquis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.46 | 2024 | Prolia, Evenity |
| Novartis Pharmaceuticals Corporation | $16.59 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Jankowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.